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Glutamineins UCP2 and UCP3 are highly similar to the mitochondrial uncoupling protein
found in the brown adipose tissue (UCP1). Accordingly, it was proposed that UCP2 and UCP3 are also
uncoupling proteins i.e. protonophores with impact on mitochondrial ROS production and glucose signaling.
However, it appears now impossible to explain the physiological relevance of the new UCPs uniquely by their
uncoupling activity as observed in vitro. Therefore, we propose a metabolic hypothesis in which UCP2 acts
through a transport distinct of the proton transport. A consequence of this transport activity would be a
decrease of the mitochondrial oxidation of the pyruvate originating from glucose. This would put UCP2 and
UCP3 in a crucial position to inﬂuence cellular metabolism. The tight control exerted on UCP2 expression
appears consistent with it. In this hypothesis, UCP2/3 would allow a cell to remain glycolytic within an
aerobic organism. This tallies with the high expression level of UCP2 or UCP3 in glycolytic cells. The
metabolic hypothesis would explain the spectacular modiﬁcations associated with UCP2 manipulation as
well as the uncoupling activity usually called for and which in fact remains elusive in vivo.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionAn increasing number of reports point to a relevance of the UCP2
for important physiological functions/events: data obtained with
mice in which UCP2 expressed has been knocked-in or knock-down,
have shown the relevance of UCP2 for the control of immune cell
function [1], cellular response to glucose and therefore insulin release
[2,3]. These observations deal with normal physiology where in some
cases the biological ﬁtness of Ucp2-KO mice appeared better [1,2].
Therefore, the presence of UCP2 has both beneﬁcial or adverse [4]
effects depending on the situation. In other studies dealing with
survival of cells/organs to shocks (ischemia–reperfusion, trauma) the
value of UCP2 (or other UCPs, see below) appeared generally positive
with remarkable cases of protection as shown for example with UCP2
in the central nervous system [5]. As UCP2 is a mitochondrial protein,
these observations have to be related to changes in mitochondrial
activity linked to the presence/absence of UCP2.
2. Uncoupling the mitochondrial respiration
UCP is the acronym for UnCoupling Protein [6], this acronym was
introduced for the mitochondrial uncoupling protein (now UCP1)
found in the brown adipose tissue of mammals. UCP1 was the ﬁrst
uncoupling protein discovered in 1976. After 1996 new UCPs were
discovered: UCP2 and UCP3 inmammals, and related proteins in otherll rights reserved.phyla including plants [7]. Concerning mitochondrial activity, uncou-
pling refers to a situation in which the mitochondrial respiration is
made less (no more) dependent upon the phosphorylation of ADP
into ATP. According to the Mitchell's chemiosmotic theory the
simplest way to achieve uncoupling would be the introduction of a
passive proton conductance in the mitochondrial inner membrane.
This is clearly what UCP1 does in the brown adipocyte. The actual
mechanism involved is still a matter of controversies [8,9]. Whatever
the mitochondrial uncoupling mechanism would be, it has several
consequences at the mitochondrial/cellular level: 1) it decreases
mitochondrial membrane potential; 2) it accelerates mitochondrial
respiration; 3) it diminishes the ATP/ADP ratio; 4) it results in a more
oxidized state of the cells (ratio NADH/NAD decreases); 5) it reduces
the mitochondrial production of reactive oxygen species. However,
the observation of one (or more) of these consequences in a cell is not
an absolute proof of uncoupling as for example: an acceleration of ATP
consumption would produce the same modiﬁcations.
The use of oligomycin provides a possibility to distinguish
uncoupling from increased ATP turnover. Oligomycin inhibits the
mitochondrial ATPsynthase. Hence, when normal mitochodrial bioe-
nergetics takes place (respiratory chain creates a proton gradient that
is used to phosphorylate ADP into ATP) oligomycin reduces cellular
respiration (often by a factor 3 or 4) and increases mitochondrial
membrane potential (around 20–50 mV more negative inside
mitochondria). If uncoupling occurs (increased proton conductance
of the mitochondrial inner membrane), the effect of oligomycin is
blunted or even abolished. Consistently, the relative differences
concerning the measurements of parameters 1, 2, 4, and 5 mentioned
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of oligomycin. It is to be mentioned that within cells it could happen
that the mitochondriawork in “reverse mode”with the mitochondrial
ATPsynthase working as an ATPase hydrolysing ATP and pumping
protons. Then addition of oligomycin would depolarize mitochondria.
The maintenance of such a situation is dependent upon a glycolytic
activity able to create an ATP/ADP ratio higher than that reached by
mitochondrial activity. Although a prominent glycolytic activity may
explain it, it is likely to be caused by a mitochondrial defect: inhibition
of respiratory chain (poisoning/hypoxia) or uncoupling. The simulta-
neous examination of variations in membrane potential, respiration
and ATP/ADP ratio may be required to clarify the effect of oligomycin
and to evidence uncoupling. The measurement of mitochondrial
membrane potential within cells is dependent on the use of probes
with which artefacts are always possible. Consequently, the sole
observation of a decreased accumulation of a potential sensitive probe
within cells is not sufﬁcient to evidence faithfully uncoupling.
BiochemistrywithpuriﬁedUCPsor isolatedmitochondria couldnot
solve unambiguously the problem either: most biochemical studies
made with the new UCPs produced data that were consistent with
these proteins being able to increase the passive protonpermeability of
the mitochondrial inner membrane [10–14]. Unfortunately, uncoupling
(proton transport) was also recorded with other proteins (transporters
of the mitochondrial inner membrane distinct from the UCPs) having
already well deﬁned activity such as the ADP/ATP translocase [15].
Therefore, whenever observed in these experiments, the debate would
turn into the physiological relevance of this uncoupling function
observed in vitro. Alternatively, one may propose that uncoupling
function is shared by a large number of related proteins that perform
also/alternatively other more specialized tasks [16,17]. The model
established by the group of Cambridge tallies now with this possibility:
This model states that mitochondrial superoxide production causes
damage tomitochondrial phospholipids and the resulting oxidized lipid
species are activators of the UCP protonophoric activity [12]. However,
the involvement of the adenine nucleotide translocase is gradually
getting more important [15,18,19]. This model has one defect: the
preventive action of the uncoupling is taking place after signiﬁcant
damage (lipid peroxidation) had occurred [20]. The possibility of
uncoupling through the activation of a proton transport activity of the
adenine nucleotide translocase was promoted by the group of V.
Skulachev in the eighties [21]. In a sense after years of efforts we have
been put “back in USSR”. The explanation of the uncoupling effect of
fatty acids (or other hydrophobic compounds) on the adenine
nucleotide translocase resides in a mechanism known as fatty acid
cycling [9,21]. It is important to recall that there are serious objections to
the possibility that this fatty acid cycling mechanismwould explain the
uncoupling activity of UCP1 in brown adipose tissue [8,22,23].
More recently, it was shown that presence of UCP2 and UCP3
signiﬁcantly increased the intensity of mitochondrial calcium uptake
within cells [24]. This uptake is performed by a yet unknown
mitochondrial calcium uniporter (MCU). However UCPs could not be
identiﬁed as the MCU, as introduction of the mammalian UCPs into
yeast failed to provide a “mammalian MCU” to the mitochondria of
this organism [24]. The acceptance of the concept that UCP2 and
UCP3 are intrinsic components of the MCU is now dependent on its
conﬁrmation by other groups. Anyway, it is important to realize that
if UCP2/3 presence increases the calcium entry into mitochondria it
is expected that the calcium would not accumulate indeﬁnitely. The
calcium extrusion out of mitochondria is dependent upon mem-
brane potential driven transporters (not ATPases), which ultimately
obtain energy from the use of the proton gradient (membrane
potential). Therefore, a futile cycle of calcium is expected to take
place that would ultimately increase the re-entry of the proton
pumped by the respiratory chain and thus increase respiration
without increasing ATP turnover. This is uncoupling. The difference
with the activity of a protonophoric UCP is an increased complexity:two or more transporters are involved. With the important
reservation associated with the effects of modiﬁed calcium signaling,
the consequences of this futile cycle of calcium in terms of
mitochondrial bioenergetics (1 to 5 above) would be identical
with that of a protonophore.
Although we have introduced the term UCP2 [25] and provided
data substantiating its uncoupling activity through the use of the yeast
expression system [10], we failed to ﬁnd evidence for the uncoupling
due to the endogenous UCP2 in mice [26]. This could have been
interpreted as a failure to provide the right activating conditions to the
proton transport activity of the protein [10–14]. We would like to
suggest the possibility that UCP2 or UCP3 have an activity distinct
from uncoupling that is physiologically relevant.
3. New UCPs and metabolism
In our recent articles we have examined successively: 1) the
consequences of recombinant expression human UCP3 in CHO cells
[27]; 2) how expression of avian UCP (avUCP) modiﬁes the activity of
yeast mitochondria [14,17]; 3) the differences between mouse embryo-
nic ﬁbroblasts (MEF) derived from wild type mice or Ucp2-knock out
mice in terms of cellular proliferation [28]; 4) ﬁnally, we have compared
the oxidative metabolism of glutamine in the macrophages of Ucp2-
knock out mice and of their wild type controls [29].
The conclusion of these studies could be summarized here: 1)
UCP3 modiﬁes bioenergetic parameters in the mitochondria of CHO
cells, these modiﬁcations did not appear consistent with uncoupling
and seemed to be associated with situations where glucose was
present in the medium. 2) Avian UCP expressed in yeast appeared
similar to UCP2: a genuine uncoupling activity is activated by retinoic
acid but the concentrations of retinoic acid that have to be used would
make its physiological signiﬁcance doubtful. However, in the absence
of activation, avUCP induced changes in yeast mitochondria bioener-
getics that were interpreted to be the result of a combination of avUCP
activity with that of other transporters naturally present in yeast
mitochondria. 3) MEF from Ucp2-KO mice differ from their wild type
counterparts in that they have a higher glucose oxidation rate and a
faster dividing activity. 4) In the presence of glutamine the macro-
phages of Ucp2-KO mice exhibit impaired homeostasis of the
glutamine derived metabolites which is associated with a partially
impaired mitochondrial bioenergetics.
Fatty acids are known stimulators of the expression of the UCP2/3
mRNA [30,31] and glutamine stimulates the translation of the UCP2
mRNA and therefore increases the mitochondrial content of UCP2
[32]. The fact that glutamine participates to the replenishment of
Krebs cycle in C4 compounds has been demonstrated experimentally
[33]. It can be concluded that stimulators of UCP2 expression (fatty
acids and glutamine) offer the possibility of feeding a complete TCA
cycle in the absence of glucose (Fig. 1). It is therefore consistent with
the expression data to propose that the role of UCP2 would be to
promote oxidation of glutamine and fatty acids rather than that of the
pyruvate derived from glucose (Figs. 1 and 2) [17,27,28].
In other words, we propose a “metabolic hypothesis” concerning
the physiological role of the new UCPs (UCP2, UCP3 inmammals), this
metabolic hypothesis is schematized in Figs. 1 and 2. It does not need
an uncoupling (proton transport) activity of the UCP but is likely to be
explained by another transport activity yet to be determined. This
means that the UCP action could be visible although uncoupling does
not take place. Something already recorded by us and others, with a
moderate overexpression of UCP3 [34] or with endogenous levels of
UCPs [29,35]. The metabolic hypothesis is therefore an alternative to
the “uncoupling hypothesis”. The two hypothesis are not mutually
exclusive. Our bet is that “time is on our side” and that the metabolic
hypothesis will be increasingly accepted as appropriate to explain the
modiﬁcations brought about by UCP2/3 activity manipulation while
with the uncoupling hypothesis “we can get no satisfaction”[36].
Fig. 2. A graphic representation of our “metabolic hypothesis” see text. The inner
membrane of mitochondria is schematized as a thick grey line with UCP2, the Krebs
cycle (K) and the respiratory chain (Resp. Chain). The Krebs cycle is schematized twice
attempting to highlight the differences between glucose (Pyruvate) or Glutamine
+Fatty acids oxidation. The respiratory chain means here all the OXPHOS system:
complexes 1–5 plus transporters for Pi and ATP/ADP. Stimulation is schematized by an
arrow, inhibition by a T ended line. The biochemical activity of the UCP2 responsible
for a decreased pyruvate oxidation is yet to be elucidated.
Fig. 1. The oxidative metabolism of glucose, fatty acids and glutamine is schematized
around the Krebs cycle (K). The relationships between fatty acids, glutamine and UCP2
expression are shown on the right.
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tion to the metabolic consequences of UCP2/3 (over)expression. We
would like to emphasize two points by which our proposal diverges
from theirs: 1)While it is not always explicitly formulated, the
common interpretation of these publications is that UCP2/3 are “fatty
acid oxidation genes”, which appears somehow contradictory with
the expression pattern. Our proposal is that UCP2/3 are “non glucose/
pyruvate oxidation genes” and we will examine later why this ﬁts
better with the expression pattern. 2) The uncoupling is usually called
for either by reference to literature, or because measurements suggest
its occurrence. Our hypothesis states that UCP2/3 act primarily
without uncoupling mitochondria.
Of course, this metabolic hypothesis does not concern UCP1 whose
physiological relevance is the mitochondrial uncoupling necessary for
cold induced thermogenesis in the brown adipose tissue. The
occurrence of this thermogenesis in adult human is nowmore widely
accepted than before [40].
4. Hypothesis: new UCPs avoid the irreversible degradation of C3
to C2
UCP3 expression is more intense in glycolytic ﬁbers [41] and the
pattern of expression of UCP2 (with the highest expression level in
spleen) [42] appears also consistent with a predominance of
expression in glycolytic cells. These expression patterns appear
contradictory with the data indicating that in cultured cells presence
of the endogenous UCP2 is associatedwith amore intense oxidation of
fatty acids while its absence is associated with an increased oxidation
of glucose [28,34,37–39,43]. To resolve this contradiction it is
necessary to emphasize the fact that our hypothesis supposes that
UCP2 is neither necessary to the oxidation of fatty acids nor promotes
directly this oxidation but UCP2 inhibits pyruvate (glucose) mito-
chondrial oxidation (Fig. 1). This brake on glucose oxidation allows
(or is compensated by) fatty acids usage (Fig. 2).
In this scheme, anaerobic glycolysis could take place from glucose
to pyruvate in a glycolytic cell but the mitochondrial degradation of a
C3 (pyruvate) product into a C2 (acetyl CoA) is avoided. In other
words, cells dependent on glycolysis could still obtain anaerobic
energy but when UCP2/3 are expressed these cells would not go
beyond the irreversible step from C3 to C2 that makes gluconeogen-
esis impossible. This obviously makes sense in a complex organism
where this glycolytic energy metabolism and the gluconeogenesis
from the C3 products occur in different cells. The gain in terms of
energy efﬁciency is limited. It just guarantees that glycolytic cells
could still be fed with glucose but their limited mitochondrial
oxidation capacities use substrates other than the pyruvate/lactate
they produce. This could explain why no dramatic phenotype of the
Ucp2/Ucp3 knock out mice have been reported with regard to
resistance to starvation.A consequence of this hypothesis would be that inside cells, the
presence of a new UCP could lead to a situationwhere glycolysis (from
glucose to pyruvate) could take place, but most of the pyruvate would
not be used by mitochondria (Figs. 1 and 2). The inhibition of
glycolysis by oxygen is known as the Pasteur effect, it is a result of the
higher efﬁciency of mitochondrial oxidation to provide ATP compared
to glycolysis. When glucose is the main substrate, mitochondrial
efﬁciency is dependent upon the oxidation of pyruvate by mitochon-
dria. Our hypothesis proposes that presence of UCP2/3 results in a
decreased afﬁnity of mitochondria for pyruvate. Therefore, for a given
mitochondrial pyruvate oxidation, UCP2/3 containing cells would
have a higher rate of glycolysis, and therefore a blunted Pasteur effect.
In hepatocytes (that do not express any of the mammalian UCPs) it
has been checked experimentally, through metabolic control analysis,
that the pyruvate oxidation exerts a signiﬁcant control over the
mitochondrial ATP production [44]. Our hypothesis predicts that this
control would be decreased in UCP2/3 expressing cells. Opposed to
the Pasteur effect is the Warburg effect where cells maintain a high
lactate production in presence of oxygen. In a recent publication the
Warburg effect in leukemia cells was associated with the presence of
UCP2 [45]. In this publication, the link between UCP2 presence and
uncoupling appeared loose enough and it leaves open the possibility
that UCP2 would not act (solely) by uncoupling respiration.
In other words: expression of UCP2 or UCP3 would allow a cell to
remain glycolytic within an aerobic organism. A conclusion consistent
with the expression pattern of both proteins.
5. From sparing to sensing: glucose sensing a main target
While UCP2 would have few consequences in quantitative terms
(amount of energy) it would deeply inﬂuence the way glucose would
control internal ATP supply which would impact glucose signaling.
This is fully veriﬁed by the set of data that pointed to UCP2 as a brake
for glucose signaling [2,3]. In these articles UCP2 action has been
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production whereas glucose would increase it.
Based on the data obtained in [28] one could make the rough
calculation shown in Fig. 3: in the presence of UCP2 about 67% of ATP
is originating from glucose oxidation whereas in its absence it is 89%.
Accordingly, within a cell devoided of UCP2 the dependence of ATP on
glucose is higher and any signaling linked to ATP/ADP ratio would be
essentially controlled by glucose. In contrast, when UCP2 is present
glucose has lost some of its strength on the control of the ATP/ADP
ratio. Therefore, within this metabolic hypothesis, UCP2 does not
counteract directly glucose signaling by lowering the ATP/ADP ratio
whatever the source of metabolic energy is. Instead, UCP2 impacts
speciﬁcally on the increase in ATP/ADP ratio linked to an intracellular
increase in glucose. It therefore lowers the amplitude of glucose
signaling. This would modify glucose sensing without compromisingFig. 3. Estimation of the relative inﬂuence of glucose and of fatty acids on ATP production in
found in our previous article [28]. (B) Calculation in terms of ATP, the assumptions are i) that
oxidation in Ucp2-KO MEF is entirely compensated by the observed increase in glucose oxi
Ucp2-KO MEF which according to basic biochemical principles should give 129 ATP. (C) Grathe energy level (ATP/ADP ratio ensured by other substrates) of the
cell. In the case of pancreatic beta cells, a high UCP2 expression level
would remain compatible with an elevated insulin secretion
(explained by a high ATP/ADP ratio?). The elevated UCP2 expression
level would just make the cell insensitive to variation in glucose level
[3]. In this respect, an explanation taking into account the metabolic
hypothesis appears more consistent with the phenotype of ob/ob
mice in which an elevated expression of UCP2 is associated with high
insulin levels in serum and loss of the sensitivity of the islet to glucose
[2]. In absence of irreversible damages to the pancreatic beta cells,
lowering UCP2 expression or inhibiting its transport activity will
increase glucose sensitivity [46]. The inclusion of this effect into the
metabolic theory [46] requires that the inhibition of the other
transport involved is similar to that of the proton transport. This is
true for the known anionic conductances of UCPs [22,47,48].Ucp2-KO or Ucp2-WT mouse embryonic ﬁbroblasts (MEF). (A) Reminding of the values
the ATP turnover is the same in both types of MEF and ii) that the decrease in palmitate
dation. Then the calculation is made for the time needed to oxidize 1 palmitic acid in
phic representation of the results.
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The link between UCP2/3 and oxygen radicals is well established
[1,5,49]. Concerning the production of oxygen radicals inmacrophages
[1], the elucidation of the role of the UCP2 has been shown to be
relatively indirect [50]. At the same time some reports indicated that
the activity of macrophages was strictly correlated to the substrate
(fatty acid or glucose) they used [51]. Consequently, it does not need
to take into account the mitochondrial production of superoxide to
explain the observations made with macrophages. Actually, the
participation of the new UCPs to the control of mitochondrial ROS
production has been contested [52]. However, the metabolic hypoth-
esis could perfectly explain how the new UCPS could decrease
mitochondrial ROS production in absence of uncoupling, hence
without impacting on energetic efﬁciency.
Fig. 2 shows an integrated view of our hypothesis. The share of
control of glucose and alternate substrates on ATP production is made
visible as well as a simpliﬁed view on ROS production. Schematically,
electrons given to the respiratory chain could follow two different
routes: the normal route leads them to water and is associated with
phosphorylation of ADP+Pi into ATP. In this scheme uncoupling is the
opening of a second “normal route” for electrons where the energy of
oxidation is lost, additive to (but also competitive with) the ATP
production. The ROS production is caused by single electrons escaping
the normal route. It is easily understandable that the ROS production
would depend upon the balance between the number of electrons that
could follow the normal route and the number of electrons getting
into the respiratory chain. So that for a given ATP turnover the ROS
production would depend on the entry of electrons into the
respiratory chain. It could be easily concluded that UCP2 by putting
a brake on the entry of glucose into the oxidation pathway lowers the
ROS production.
Here also the expression of the UCPs in glycolytic cells makes
sense. In these cells pyruvate production is intense. This pyruvate
would put a enormous redox pressure on the mitochondrial
respiratory chain with the risk of a high ROS production. UCP2 by
counteracting pyruvate admission into the Krebs cycle would protect
themitochondria inside glycolytic cells. Similarly towhat is said above
concerning glucose sensing, this defense against oxygen radicals
within glycolytic cells would impact directly on the origin of the
problem (pyruvate abundance) and it would not jeopardize through
uncoupling the other sources of metabolic energy. Obviously, this
protection is needed more when alternate mitochondrial substrates
are available and the stimulation of UCP2 expression by fatty acids and
glutamine remains understandably independent of the conditions
where glucose needs to be spared. In fact it appears likely that the
lowering of ROS production when a combination of substrates is
present would be the primitive role for the UCPs. Its relevance to
glucose sparing and signaling gained importance as the complexity of
organisms increased.
This role in glycolytic cells appears highly relevant to the
consequences of ischemic shocks.
7. UCPs and ischemic shocks
Several reports pointed to the UCPs overexpressed by genetic
engineering as remarkably able to protect cells from the consequences
of ischemic [5,53,54] or even traumatic events [5]. Here again
uncoupling has been called for as an explanation. Uncoupling would
limit mitochondrial membrane potential during reperfusion, this
would reduce both ROS production and calcium uptake. In this respect
the recent proposal that mitochondrial calcium entry is increased
when UCP2 or UCP3 are overexpressed appears at odds with their
protective effect on reperfusion. In the case of UCP1 we have clearly
evidenced that its protective role in the reperfused heart of transgenic
mice requires a quantitatively signiﬁcant uncoupling that maintainsthe respiratory activity to its maximal value although ATP turnover is
reduced [54]. Concerning UCP2 [5] while the authors could record
spectacular protective effects, the demonstration of uncoupling could
not be provided and authors eventually turned to other explanations
including ROS partitioning [5].
During ischemia cells have no other choice than to turn to
anaerobic glycolysis to obtain energy. When reperfusion takes place
themitochondria of these cells will be put in a situation comparable to
that of glycolytic cells (see above). This is likely to be aggravated by
the fact that the ischemic cells, whose survival is most required are
differentiated cells where mitochondria are much more abundant
than in the “normal glycolytic cell”. Therefore, the potency of ROS
production is enormous and so are the potential damages associated
to it. Consequently, during the ischemic period turning to glycolysis is
a condition for survival but it becomes a threat during reperfusion due
to the ROS production derived from the increased glucose usage. In
this scheme the value of UCP2/3 as a brake for pyruvate entry into
mitochondria might be considerable and it may explain while
spectacular effects could be recorded in absence of uncoupling of
respiration. Moreover, the protective effect of uncoupling is contested
[55,56].
8. Conclusion
While the effect of UCP2/3 on cellular metabolism is ﬁrmly
established we still miss conclusive evidence about the transport
activity that explains this effect. In this respect both hypotheses
(metabolic or uncoupling) still require experimental support. It may
appear as provocative concerning the uncoupling hypothesis. How-
ever, in many publications uncoupling remains an interpretation
based on observations made in cells/animals correlated with the
existing biochemical knowledge obtained in vitro. It must also be
emphasized that the observation that chemical uncouplers mimick
some of the effects of a UCP inside a cell is not a proof that the UCP acts
by uncoupling. Mild uncoupling was proposed initially independently
(before) the discovery of the new UCPs, reviewed in [57], as a mean to
prevent superoxide formation in mitochondria. When these newUCPs
arose, the mild uncoupling found conveniently two genes and
consequently mild uncoupling was associated to their expression
even if it could not be quantitatively detected. At the opposite, when
we examined more carefully our models where the effect of the new
UCP could have been interpreted as the result of an uncoupling
activity, we failed to demonstrate evidence for uncoupling and in fact
accumulated evidence against it. Actually, our work concerning
glutamine metabolism [29] shows a situation where UCP2 changes
mitochondrial metabolism in the absence of any uncoupling activity.
Accordingly, it appears now impossible to us to explain the
physiological relevance of the new UCPs uniquely by their uncoupling
activity as observed in vitro.
This has led to the formulation of a metabolic hypothesis fully
consistent with knowledge concerning the control of the expression of
the UCP2. In the absence of uncoupling, another transport activity of
the UCP may be involved. In its simplest form the metabolic
hypothesis would be explained by a uniport for anionic pyruvate
lowering mitochondrial afﬁnity for pyruvate as membrane potential
increases [27]. UCP2 or UCP3 are obvious candidates to be this
pyruvate anionic uniport but the proof is far from being produced.
Elucidation of the role of the new UCPs in absence of uncoupling
would need the study with resolutive metabolic analysis (NMR?) of
the internal pathways for metabolites in presence/absence of the new
UCP coupled with re-examination of the various solutes that could be
transported by UCP2/3.
We have suggested here that this metabolic hypothesis explains
why important modiﬁcations linked to UCP2 activity have been
recorded although in some cases clear evidence for mitochondrial
uncoupling was missing. Moreover, the metabolic hypothesis appears
382 F. Bouillaud / Biochimica et Biophysica Acta 1787 (2009) 377–383more speciﬁc and would not lead to a waste of energy which is a
obligatory consequence of uncoupling. This would not mean that
uncoupling by the new UCPs is not relevant to physiology but it would
rather be a secondary/side effect of these proteins [58], while their
role in the control of glucose/pyruvate metabolism would explain
their existence in so many different organisms.
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